We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Information for patients, healthcare professionals and developers of new medicines
Advises on how to consider light within the planning system.
Explore the impact of parental conflict on children and young people.
Check what side effects people have reported when they've taken a medicine.
A cross-sectional study on the protective role of parental monitoring, religiosity, and self-esteem
Whether you’re a patient, healthcare professional or carer, this year’s #MedSafetyWeek campaign is calling on you to help improve the safety of medical products by reporting any suspected side effects and adverse incidents to the MHRA Yellow Card scheme.
Systemic fluoroquinolones must now only be prescribed when other commonly recommended antibiotics are inappropriate. This follows a review by the MHRA which looked at the effectiveness of current measures to reduce the identified risk of disabling and potentially long-lasting or...
How the maritime industry should treat waste at sea and in ports, reduce oil and air pollution, and control ozone-depleting substances.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
How to use an interrupted time series to evaluate your digital health product.
Forms for the notification of serious undesirable effects (SUEs) from cosmetic products in Great Britain.
Find out about the long-term effects some people can have after having COVID-19.
Who you should contact if a pet or other animal or human has an unexpected reaction to a veterinary medicine or a problem with a microchip
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
Climate change is happening and is due to human activities; along with warming, many other changes are occurring such as melting polar ice, rising sea levels and more frequent floods, droughts and heatwaves.
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Healthcare professionals should be vigilant for suspected adverse reactions and safety concerns associated with e-cigarettes and e-liquids, commonly known as vapes. Please report adverse reactions to the Yellow Card scheme and promote vigilance among patients.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).